Potassium Blood Test (2026): Normal Range, High & Low Potassium, Hyperkalemia, Hypokalemia & Laboratory Interpretati

Potassium Blood Test 2026 normal range high and low potassium hyperkalemia hypokalemia laboratory interpretatio


Potassium blood test: normal range, high and low potassium, and laboratory interpretation.

Last Updated: August 22, 2026 This MedLab Academy laboratory guide reviews serum and plasma potassium testing, normal ranges, hyperkalemia, hypokalemia, pseudohyperkalemia, specimen handling, analytical methods, interferences, quality control, critical results, and evidence-based laboratory interpretation.

The potassium blood test is one of the most important and frequently requested electrolyte measurements in clinical chemistry. Potassium, reported as K+, plays a critical role in maintaining membrane potential, nerve conduction, skeletal and smooth muscle function, and normal cardiac electrical activity. Because relatively small changes in extracellular potassium may have important physiological consequences, an abnormal potassium result can require careful laboratory verification and, in some situations, urgent clinical attention.

Despite appearing to be a simple electrolyte measurement, serum potassium interpretation is highly dependent on preanalytical quality. Hemolysis, prolonged tourniquet application, repeated fist clenching, delayed separation, contamination with potassium-containing solutions, platelet release during clotting, and extreme leukocytosis can all alter the reported value. For this reason, a laboratory professional should never interpret an unexpected high or low potassium result solely by comparing it with the reference interval.

This article takes a laboratory-centered approach to the potassium blood test normal range, causes of high potassium and low potassium, recognition of pseudohyperkalemia, specimen requirements, serum versus plasma potassium, ion-selective electrode methodology, quality control, critical-value handling, and clinically appropriate result interpretation.

Key Laboratory Points

  • Potassium is the major intracellular cation; only a small fraction of total body potassium is present extracellularly.
  • A commonly cited serum potassium range is approximately 3.5–5.0 mmol/L, but laboratories must use their own validated reference interval.
  • Hyperkalemia should be distinguished from pseudohyperkalemia before an unexpected result is acted upon whenever the clinical situation permits.
  • Hemolysis is one of the most important causes of falsely elevated potassium; see the Hemolysis in Clinical Chemistry guide for a deeper review of H-index interpretation and laboratory interference.
  • Serum potassium may be slightly higher than plasma potassium because platelets release potassium during clot formation.
  • Severe hyperkalemia and severe hypokalemia may cause dangerous cardiac arrhythmias and require urgent clinical assessment.
  • A potassium result should be interpreted alongside renal function, acid-base status, medications, magnesium, glucose, and the clinical picture.

What Is Potassium?

Potassium is an essential electrolyte and the principal positively charged ion inside human cells. The overwhelming majority of total body potassium is intracellular, especially within skeletal muscle. In contrast, only a relatively small fraction is present in extracellular fluid and blood.

This distribution creates a concentration gradient across cell membranes that is fundamental to electrical excitability. The gradient is maintained primarily by the sodium-potassium ATPase pump, which transports potassium into cells while moving sodium out of cells.

Because cardiac myocytes, skeletal muscle fibers, and neurons depend on stable transmembrane electrical gradients, marked abnormalities in extracellular potassium can interfere with normal conduction and muscle function.

The kidneys are the major regulators of potassium balance. Potassium absorbed from the diet enters the extracellular compartment and is subsequently redistributed into cells or excreted, predominantly through the kidneys. Renal potassium handling is influenced by aldosterone, distal sodium delivery, urine flow, acid-base status, kidney function, and several medications.

The U.S. National Institutes of Health Office of Dietary Supplements notes that serum potassium typically lies around 3.6–5.0 mmol/L, while also emphasizing that blood potassium does not perfectly represent total body potassium because most potassium is located inside cells.

Why Is a Potassium Blood Test Ordered?

A potassium blood test is commonly included in routine chemistry panels such as a basic metabolic panel or comprehensive metabolic panel. It may also be specifically requested when a clinician suspects an electrolyte disorder or needs to monitor a patient at increased risk of abnormal potassium.

Common indications include:

  • Routine health assessment.
  • Known or suspected kidney disease.
  • Acute kidney injury.
  • Monitoring patients taking diuretics.
  • Monitoring ACE inhibitors, ARBs, mineralocorticoid receptor antagonists, or other medications that affect potassium.
  • Cardiac arrhythmias or palpitations.
  • Muscle weakness or paralysis.
  • Prolonged vomiting or diarrhea.
  • Adrenal disorders.
  • Diabetic ketoacidosis or severe hyperglycemia; related glucose interpretation is reviewed in the Blood Glucose Test guide.
  • Acid-base disturbances.
  • Critical illness.
  • Monitoring during potassium replacement.
  • Evaluation of an abnormal ECG in the appropriate clinical context.

The potassium result is rarely interpreted in isolation. Depending on the clinical situation, the laboratory or clinician may also review sodium, chloride, bicarbonate or total CO2, magnesium, calcium, creatinine, estimated glomerular filtration rate, glucose, urea, and blood gas findings.

Potassium Blood Test Normal Range

One of the most searched questions is: What is the normal potassium range in a blood test?

There is no single universal reference interval that applies to every laboratory. Reference limits depend on the specimen type, analytical system, local population, laboratory validation, and method.

A commonly encountered adult serum potassium reference interval is approximately:

Potassium Category Approximate Value Interpretive Note

Typical reference interval About 3.5–5.0 mmol/L Exact limits vary by laboratory and analyzer.
Low potassium <3.5 mmol/L Often termed hypokalemia.
Marked/severe hypokalemia <2.5 mmol/L May be associated with serious neuromuscular and cardiac complications.
High potassium Above the laboratory upper reference limit Often termed hyperkalemia; thresholds vary.
Severe hyperkalemia ≥6.5 mmol/L in UK Kidney Association guidance Requires urgent clinical assessment in the appropriate setting.

Reference interval vs clinical decision limit: A laboratory reference interval is not identical to an emergency-action threshold. Clinical urgency depends on the potassium concentration, rate of change, symptoms, ECG findings, kidney function, medications, and the possibility of a spurious laboratory result.

For example, NIH Office of Dietary Supplements describes serum potassium concentrations of approximately 3.6–5.0 mmol/L as normal, whereas another U.S. National Library of Medicine reference gives an example range of 3.7–5.2 mmol/L. The difference illustrates why the result should always be interpreted using the reference interval printed on the laboratory report.

Serum vs Plasma Potassium

Potassium can be measured in serum or plasma, but these specimens are not perfectly interchangeable.

Serum potassium

Serum is obtained after blood is allowed to clot. During clot formation, platelets can release potassium. As a result, serum potassium may be slightly higher than plasma potassium in the same patient.

Plasma potassium

Plasma is obtained from anticoagulated blood. For potassium measurement, lithium-heparin plasma is commonly used in clinical chemistry.

The serum-plasma difference becomes particularly important in patients with extreme thrombocytosis. A patient may appear hyperkalemic when serum is analyzed even though plasma potassium is within the expected range.

When pseudohyperkalemia related to platelet release is suspected, comparing serum potassium with appropriately collected plasma or whole-blood potassium can provide valuable laboratory information.

High Potassium: Hyperkalemia

Hyperkalemia refers to potassium above the applicable upper reference or clinical decision limit. Depending on the definition used, values above approximately 5.0 or 5.5 mmol/L may be classified as elevated.

The clinical importance of hyperkalemia lies primarily in its potential effect on cardiac conduction. However, the relationship between potassium concentration and cardiac toxicity is not perfectly predictable. Some patients with chronic elevation may have relatively few symptoms, while others may develop significant electrophysiological abnormalities.

UK Kidney Association guidance classifies persistent community hyperkalemia broadly as:

Category Serum K+
Mild 5.5–5.9 mmol/L
Moderate 6.0–6.4 mmol/L
Severe ≥6.5 mmol/L

These categories are clinical decision thresholds from a specific guideline and should not be substituted for an individual laboratory's reference interval or critical-value policy.

Causes of High Potassium

True hyperkalemia generally develops from one or more of three major mechanisms:

  1. Reduced potassium excretion.
  2. Movement of potassium from cells into extracellular fluid.
  3. Excessive potassium administration or intake in a susceptible patient.

1. Reduced renal potassium excretion

The kidneys are the primary route for potassium removal. Therefore, impaired renal excretion is one of the most important causes of hyperkalemia.

Possible settings include:

  • Acute kidney injury.
  • Advanced chronic kidney disease.
  • Hypoaldosteronism.
  • Adrenal insufficiency.
  • Reduced distal sodium delivery.
  • Medications that reduce renal potassium excretion.

2. Transcellular potassium shift

A shift of potassium from the intracellular space into extracellular fluid can elevate plasma or serum potassium even without an overall increase in total body potassium.

Situations associated with extracellular potassium shifts can include:

  • Insulin deficiency.
  • Hyperosmolar states.
  • Some forms of acidosis.
  • Cellular injury.
  • Rhabdomyolysis.
  • Tumor lysis.
  • Severe tissue trauma.
  • Hemolysis occurring within the patient.

3. Potassium intake or administration

Dietary potassium alone rarely produces dangerous hyperkalemia in healthy individuals with normal renal function because the kidneys can usually increase urinary excretion.

Risk changes substantially when renal excretion is impaired. Potassium supplements, intravenous potassium, or potassium-containing salt substitutes may contribute to clinically important hyperkalemia in susceptible patients.

Pseudohyperkalemia: When High Potassium Is Not Truly High

Pseudohyperkalemia is a laboratory phenomenon in which the measured potassium concentration is higher than the patient's true circulating potassium concentration.

Recognizing pseudohyperkalemia is one of the most important laboratory responsibilities in electrolyte testing because unnecessary treatment of a falsely high potassium result could produce true hypokalemia.

Common causes or contributors include:

  • In-vitro hemolysis.
  • Traumatic venipuncture.
  • Repeated fist clenching.
  • Prolonged tourniquet use.
  • Delayed serum or plasma separation.
  • Extreme thrombocytosis.
  • Extreme leukocytosis.
  • Specimen transport-related cell injury.
  • Improper storage or handling.
  • Contamination from potassium-containing material.

When should the laboratory suspect pseudohyperkalemia?

Suspicion increases when an unexpectedly high potassium result is inconsistent with previous values, renal function, medications, clinical findings, or ECG information.

A significantly elevated hemolysis index strengthens suspicion of an in-vitro artifact. However, the laboratory should follow analyzer-specific and locally validated hemolysis thresholds rather than applying a universal correction factor.

Laboratory principle: Do not mathematically “correct” a hemolyzed potassium concentration using a generic formula. The effect of hemolysis varies according to the degree of red-cell disruption, specimen characteristics, analyzer, and method. Follow the laboratory's validated interference policy.

Hemolysis and Potassium

Red blood cells contain substantially more potassium than plasma. When erythrocytes rupture after specimen collection, intracellular potassium leaks into serum or plasma, potentially producing a falsely elevated result.

MedlinePlus specifically notes that injury to red blood cells during blood collection can release potassium and result in a falsely high potassium measurement.

Causes of in-vitro hemolysis can include:

  • Difficult or traumatic venipuncture.
  • Use of an inappropriate needle size.
  • Excessive suction during collection.
  • Forceful transfer of blood through a needle.
  • Vigorous shaking of tubes.
  • Improper specimen transport.
  • Temperature extremes.
  • Collection from an unsuitable line or catheter.

What should the laboratory do?

If the potassium result is affected by hemolysis beyond the analyzer's validated interference limit, the laboratory should follow its standard operating procedure. Depending on local policy and the clinical circumstances, this may involve suppressing the result, adding an interpretive comment, notifying the clinical team, or requesting recollection.

A critical result should never simply be ignored because hemolysis is present. The laboratory must balance analytical validity with patient safety and follow its approved critical-result policy.

EDTA Contamination and Falsely High Potassium

Potassium-EDTA contamination is a classic preanalytical cause of unexpectedly elevated potassium.

EDTA tubes used for hematology commonly contain potassium salts such as K2EDTA or K3EDTA. If EDTA contaminates a chemistry specimen, potassium may rise markedly.

At the same time, EDTA chelates divalent cations. Therefore, an unusual biochemical pattern such as:

  • Very high potassium,
  • Unexpectedly low calcium,
  • Unexpectedly low magnesium,
  • and sometimes low alkaline phosphatase activity

may raise suspicion for EDTA contamination, although interpretation must consider the entire clinical and laboratory context.

Avoiding cross-contamination requires correct phlebotomy technique and adherence to the laboratory's approved order of draw.

Thrombocytosis, Leukocytosis and Potassium Results

Thrombocytosis

During clotting, platelets release potassium. This becomes especially relevant in thrombocytosis, where serum potassium can be spuriously increased. In marked thrombocytosis, serum potassium can therefore become significantly higher than plasma potassium.

When this phenomenon is suspected, a heparinized plasma specimen may better reflect the circulating potassium concentration.

Extreme leukocytosis

Very high white blood cell counts can also complicate potassium measurement. Fragile leukemic cells may rupture during collection, transport, storage, centrifugation, or pneumatic-tube transport, causing potassium release.

In some hematologic conditions, unusual discrepancies can occur between serum, plasma, and whole-blood potassium. The laboratory should interpret such cases in conjunction with the CBC, specimen handling history, transport method, and clinical information.

Low Potassium: Hypokalemia

Hypokalemia is generally defined as serum or plasma potassium below approximately 3.5 mmol/L, although the laboratory's validated reference interval should always be used.

NHS Specialist Pharmacy Service guidance classifies hypokalemia as:

Category Potassium
Mild 3.0–3.5 mmol/L
Moderate 2.5–2.9 mmol/L
Severe <2.5 mmol/L

The clinical effect depends not only on the numerical value but also on how rapidly the potassium declined, underlying cardiac disease, magnesium concentration, medications, and other electrolyte disturbances.

Causes of Low Potassium

Hypokalemia can result from gastrointestinal loss, renal loss, intracellular redistribution, or less commonly inadequate intake alone.

1. Gastrointestinal loss

  • Diarrhea.
  • Vomiting, often through secondary renal mechanisms associated with alkalosis and volume depletion.
  • Excessive laxative use.
  • Gastrointestinal drainage.

2. Renal potassium loss

  • Loop diuretics.
  • Thiazide diuretics.
  • Mineralocorticoid excess.
  • Renal tubular disorders.
  • Some medications causing renal electrolyte wasting.
  • Magnesium deficiency.

3. Shift of potassium into cells

  • Insulin administration.
  • Beta-adrenergic stimulation.
  • Alkalemia.
  • Refeeding-related intracellular shifts.
  • Some forms of periodic paralysis.

4. Reduced intake

Low dietary potassium alone is an uncommon cause of substantial hypokalemia in otherwise healthy people, but inadequate intake may contribute when combined with gastrointestinal or renal losses.

Magnesium and Refractory Hypokalemia

Magnesium deserves special attention whenever hypokalemia is persistent or difficult to correct.

Magnesium depletion can promote renal potassium wasting, making potassium replacement less effective until magnesium deficiency is recognized and corrected.

NIH notes that magnesium depletion can contribute to hypokalemia by increasing urinary potassium loss and may increase the risk of cardiac arrhythmias.

For this reason, checking magnesium is often appropriate in clinically significant, persistent, or unexplained hypokalemia.

Symptoms of High and Low Potassium

Both hyperkalemia and hypokalemia may be asymptomatic, particularly when mild or developing gradually.

Possible symptoms of hyperkalemia

  • Muscle weakness.
  • Fatigue.
  • Paresthesia or tingling.
  • Nausea.
  • Palpitations; when cardiac injury is also part of the differential, related laboratory context is covered in the Cardiac Biomarkers guide.
  • Abnormal heart rhythm.

Possible symptoms of hypokalemia

  • Muscle weakness.
  • Muscle cramps.
  • Fatigue.
  • Constipation.
  • Palpitations.
  • Arrhythmias.
  • Severe weakness or paralysis in marked deficiency.

Safety note: Symptoms cannot reliably determine potassium concentration. Severe electrolyte abnormalities may occur with few symptoms, while similar symptoms may result from many unrelated disorders.

Potassium Specimen Collection and Handling

Accurate potassium measurement begins before the sample reaches the analyzer.

Common specimen types

  • Serum.
  • Lithium-heparin plasma.
  • Heparinized whole blood for blood-gas or point-of-care systems.

The laboratory should define the acceptable specimen type for each analyzer and must avoid comparing results across specimen types without considering methodological and matrix differences.

Patient preparation

A potassium blood test typically does not require fasting when ordered alone. However, fasting may be required when potassium is included with other laboratory tests.

Patients should not stop prescription medicines solely because they are having a potassium test unless specifically instructed by their healthcare professional.

Collection technique

To minimize preanalytical variation:

  • Use appropriate venipuncture technique.
  • Avoid unnecessary prolonged tourniquet application.
  • Avoid repeated vigorous fist clenching.
  • Prevent traumatic collection.
  • Mix anticoagulated tubes according to manufacturer instructions without vigorous shaking.
  • Follow the correct order of draw.
  • Avoid contamination from IV fluids.

Preanalytical Errors in Potassium Testing

Potassium is among the laboratory analytes most vulnerable to preanalytical error.

Preanalytical Issue Possible Effect Laboratory Consideration

Hemolysis False increase Review hemolysis index and analyzer interference limit.
Repeated fist clenching Possible increase Avoid repeated vigorous hand pumping during collection.
Prolonged contact with cells Potential alteration Process specimens according to validated stability requirements.
EDTA contamination Marked false increase Review order of draw and associated calcium/magnesium abnormalities.
Extreme thrombocytosis High serum K Compare with plasma if pseudohyperkalemia suspected.
Extreme leukocytosis Spurious high or method-dependent discrepancy Review CBC, transport, and specimen type.
IV contamination Variable Recollect appropriately when contamination is suspected.

Laboratory Methods for Potassium Measurement

Modern clinical laboratories primarily measure potassium using ion-selective electrode (ISE) technology.

An ion-selective membrane responds preferentially to potassium ions. The potential generated across the membrane is related to ion activity and is converted by the analyzer into a reportable concentration according to the instrument's calibration system.

ISE systems may be broadly divided into:

  • Direct ISE.
  • Indirect ISE.

Both are widely used, but they differ in sample handling and dilution.

Direct vs Indirect ISE

Direct ISE

Direct ISE measures electrolyte activity in an undiluted sample. It is commonly used by blood-gas analyzers and some point-of-care instruments.

Indirect ISE

Indirect ISE measures electrolytes after sample dilution and is common in high-throughput chemistry analyzers.

Feature Direct ISE Indirect ISE

Sample Undiluted Diluted
Common platforms Blood-gas/POC systems Main chemistry analyzers
Effect of abnormal solids Less influenced by sample water-fraction assumptions Potentially affected for some electrolytes when solids are extreme

For potassium specifically, laboratories should interpret method comparison results using validated analyzer performance rather than assuming that two instruments are automatically interchangeable.

Quality Control for Potassium Testing

Potassium is a clinically important measurand, so reliable internal quality control is essential before patient results are released.

A robust potassium QC program may include:

  • At least two relevant control concentrations according to the laboratory's QC plan.
  • Regular review of Levey–Jennings charts.
  • Assessment for shifts and trends.
  • Appropriate Westgard or laboratory-defined rejection rules.
  • Calibration and calibration-verification procedures where applicable.
  • Review of reagent and calibrator lot changes.
  • External quality assessment or proficiency testing, alongside broader Laboratory Quality Indicators (QIs) used to monitor analytical and post-analytical performance.
  • Instrument maintenance and electrode performance monitoring.
  • Method comparison after major analyzer or reagent changes where required.

If potassium QC is out of range

The laboratory should not release patient results affected by an analytically unacceptable run until the problem has been investigated according to the approved SOP.

Investigation may include:

  1. Reviewing the QC material and preparation, with reference to the Internal Quality Control (IQC) guide when Westgard rules, shifts, trends, or control failure need structured evaluation.
  2. Checking expiration dates and storage conditions.
  3. Reviewing calibration status.
  4. Inspecting reagents and electrode performance.
  5. Checking maintenance records.
  6. Repeating QC when scientifically justified.
  7. Evaluating systematic versus random error.
  8. Documenting corrective action.
  9. Assessing whether previously released patient results could have been affected.

Critical Potassium Results

There is no globally universal critical potassium threshold that every laboratory must use.

Each laboratory should establish and approve its critical-value limits in consultation with clinical leadership, based on patient population, institutional policy, accreditation requirements, and applicable professional guidance.

Nevertheless, severe potassium abnormalities commonly trigger urgent communication protocols.

UK Kidney Association guidance identifies serum potassium ≥6.5 mmol/L as severe hyperkalemia and recommends immediate hospital assessment for severe community hyperkalemia.

For hypokalemia, NHS Specialist Pharmacy Service guidance classifies potassium <2.5 mmol/L as severe.

Important: These thresholds are provided for educational context and should not replace the critical limits or escalation procedure established by an individual laboratory or healthcare institution.

Potassium and ECG Changes

Potassium disturbances can affect cardiac membrane excitability and conduction, but ECG findings do not correlate perfectly with the measured potassium concentration.

Hyperkalemia may be associated with:

  • Tall, peaked T waves.
  • PR prolongation.
  • P-wave changes.
  • QRS widening.
  • Severe conduction disturbances.

Hypokalemia may be associated with:

  • T-wave flattening.
  • ST-segment depression.
  • Prominent U waves.
  • Increased susceptibility to arrhythmia.

The absence of obvious ECG abnormalities does not necessarily prove that a severe potassium disturbance is safe. Clinical management should be determined by qualified clinicians.

Potassium and Kidney Function

Kidney function is central to potassium homeostasis.

As kidney function declines, the body initially adapts by increasing potassium secretion in remaining functional nephrons and through gastrointestinal mechanisms. However, the risk of hyperkalemia rises when renal reserve becomes insufficient or when additional factors are present.

Risk factors can include:

  • Advanced CKD; kidney-related biochemical interpretation can also be complemented by the High Uric Acid Blood Test guide.
  • Acute kidney injury.
  • Diabetes and HbA1c monitoring.
  • Heart failure.
  • Hypoaldosteronism.
  • ACE inhibitor or ARB use.
  • Mineralocorticoid receptor antagonists.
  • Potassium supplements.
  • Potassium-containing salt substitutes.

KDIGO guidance emphasizes management strategies that consider medications, dietary potassium sources, kidney function, and the clinical benefit of renin-angiotensin-aldosterone system inhibitors rather than automatically discontinuing beneficial therapy without individualized assessment.

Potassium and Acid-Base Disorders

Potassium balance and acid-base physiology are closely connected, but the relationship is more complex than the simplified idea that “acidosis always raises potassium.”

Extracellular-intracellular potassium shifts vary according to the type and cause of the acid-base disturbance, insulin activity, kidney function, and the accompanying anions.

Laboratory interpretation of an abnormal potassium should therefore consider:

  • Bicarbonate or total CO2.
  • Blood gas findings where indicated.
  • Glucose concentration.
  • Anion gap when clinically relevant.
  • Renal function.
  • Clinical history.

For example, patients with diabetic ketoacidosis may present with normal or elevated serum potassium despite substantial total-body potassium depletion. During treatment, potassium may shift intracellularly and the measured serum concentration can fall.

Medications That Can Affect Potassium

Medication review is essential when evaluating unexplained hyperkalemia or hypokalemia.

Medications associated with increased potassium may include:

  • ACE inhibitors.
  • Angiotensin receptor blockers.
  • Mineralocorticoid receptor antagonists.
  • Potassium-sparing diuretics.
  • Some NSAIDs.
  • Heparin in certain settings.
  • Calcineurin inhibitors.
  • Potassium supplements.

Medications associated with decreased potassium may include:

  • Loop diuretics.
  • Thiazide diuretics.
  • Some beta-agonists through intracellular shifting.
  • Insulin through intracellular shifting.
  • Some medications producing gastrointestinal or renal losses.

Medication lists should always be reviewed by a healthcare professional. Patients should not stop prescribed medication solely because they read that it may alter potassium.

Urine Potassium Testing

Urine potassium measurement may help determine whether potassium loss is predominantly renal or extrarenal in selected patients. For broader urine testing principles, see the Urinalysis (UA) guide.

Possible approaches include:

  • Spot urine potassium.
  • Urine potassium-to-creatinine relationships in appropriate clinical contexts.
  • 24-hour urine potassium collection.

Interpretation requires caution because urinary potassium excretion is influenced by dietary intake, kidney function, aldosterone activity, urine flow, acid-base status, medications, and timing.

Urine potassium should therefore be interpreted as part of a clinical evaluation rather than as a stand-alone diagnosis.

Laboratory Interpretation Algorithm for an Abnormal Potassium Result

Step 1: Verify patient and specimen identification

Confirm that the specimen belongs to the correct patient and that labeling and accessioning are accurate.

Step 2: Review specimen quality

Assess hemolysis, clotting where inappropriate, collection tube, sample volume, storage, and transport conditions.

Step 3: Review the hemolysis index

An elevated hemolysis index may explain an unexpectedly high potassium. Apply analyzer-specific interference criteria.

Step 4: Compare with previous potassium results

A large unexpected delta may warrant review of specimen quality, prior values, renal function, medications, and clinical context.

Step 5: Review associated analytes

Useful parameters can include:

  • Creatinine and eGFR.
  • Urea.
  • Sodium.
  • Bicarbonate/CO2.
  • Glucose.
  • Magnesium.
  • Calcium.
  • CBC when thrombocytosis or leukocytosis is suspected.

Step 6: Consider contamination

An implausibly high potassium accompanied by unexpectedly low calcium and magnesium may raise suspicion for potassium-EDTA contamination.

Step 7: Consider pseudohyperkalemia

If the clinical picture does not fit the result, consider hemolysis, thrombocytosis, leukocytosis, collection technique, transport, and serum-plasma differences.

Step 8: Apply the critical-result policy

If the value meets institutional critical criteria, follow the approved notification and documentation process.

Step 9: Repeat or recollect only when appropriate

Repeat testing should be clinically and analytically justified rather than automatic. Recollection may be necessary when the original specimen is compromised.

Laboratory Case Examples

Case 1: Potassium 6.2 mmol/L with marked hemolysis

A chemistry specimen produces potassium of 6.2 mmol/L. The hemolysis index is well above the manufacturer's validated interference threshold.

The appropriate laboratory response is not to assume that the patient has true severe hyperkalemia. The result should be handled according to the laboratory's hemolysis and critical-result SOP, and recollection may be required.

The important lesson is that potassium released from damaged blood cells can substantially affect the measured result.

Case 2: Serum potassium 5.8 mmol/L with extreme thrombocytosis

A patient has a very high platelet count and repeated serum potassium results around 5.8 mmol/L despite no clinical evidence of hyperkalemia.

Platelet potassium release during clotting may contribute to pseudohyperkalemia. Comparing a correctly collected plasma or whole-blood potassium result can help clarify the discrepancy.

Case 3: Potassium 2.7 mmol/L with low magnesium

A patient has persistent hypokalemia despite potassium replacement, and laboratory testing also shows significant hypomagnesemia.

Magnesium depletion can promote renal potassium wasting. The finding is therefore clinically relevant to understanding why potassium remains low.

Case 4: Potassium 7.0 mmol/L, normal hemolysis index

A potassium of 7.0 mmol/L without significant hemolysis should be treated as potentially genuine and clinically dangerous rather than dismissed as laboratory error.

The laboratory should follow its critical-value communication procedure promptly while considering previous results, renal function, sample quality, and the clinical context.

Case 5: Potassium 7.4 mmol/L with very low calcium after phlebotomy

If potassium is unexpectedly very high while calcium is unusually low and the patient's previous chemistry profile was normal, EDTA contamination should enter the differential for a spurious specimen.

A properly recollected specimen is generally necessary when contamination is suspected.

Frequently Asked Questions About Potassium Blood Tests

What is a normal potassium level?

A commonly used adult serum potassium interval is around 3.5–5.0 mmol/L, but exact reference limits vary between laboratories. NIH cites approximately 3.6–5.0 mmol/L, while other laboratories may use slightly different limits.

Is potassium 5.1 mmol/L high?

It may be slightly above the upper limit in some laboratories and within range in others. Interpretation depends on the laboratory reference interval, specimen type, collection quality, medications, kidney function, and clinical context.

What potassium level is considered dangerous?

There is no single universal danger threshold. UK Kidney Association guidance defines serum potassium ≥6.5 mmol/L as severe hyperkalemia requiring urgent assessment. Individual laboratory critical limits may differ.

What potassium level is severely low?

Many clinical guidelines classify potassium below 2.5 mmol/L as severe hypokalemia. Severity also depends on symptoms, ECG findings, underlying disease, medications, and the speed of decline.

What causes high potassium in a blood test?

Possible causes include kidney dysfunction, reduced aldosterone activity, medications, cell injury, insulin deficiency, acid-base disturbances, potassium administration, or a falsely elevated result caused by specimen problems such as hemolysis.

Can hemolysis cause high potassium?

Yes. Red blood cells contain substantial intracellular potassium. If they rupture after collection, potassium may leak into serum or plasma and cause a falsely elevated measurement.

Can squeezing the fist raise potassium?

Repeated vigorous fist clenching during blood collection can contribute to an increased potassium measurement and should be avoided when possible.

Can dehydration cause high potassium?

Dehydration alone does not explain every elevated potassium result. Depending on severity and associated renal impairment, acid-base changes, medications, and underlying illness, it may contribute indirectly. A full clinical assessment is needed.

Can kidney disease cause hyperkalemia?

Yes. Reduced renal potassium excretion is an important cause of hyperkalemia, particularly in advanced CKD or acute kidney injury and when combined with medications that reduce potassium excretion.

Does high potassium always cause symptoms?

No. Hyperkalemia can be asymptomatic. Therefore, symptoms alone cannot be used to determine whether potassium is dangerously elevated.

What causes low potassium?

Common causes include diarrhea, vomiting-related losses, diuretics, renal potassium wasting, magnesium deficiency, insulin-related intracellular shifting, beta-adrenergic stimulation, and certain endocrine disorders.

Why check magnesium when potassium is low?

Magnesium deficiency can increase renal potassium loss and contribute to persistent or difficult-to-correct hypokalemia.

Is serum potassium the same as plasma potassium?

Not exactly. Serum potassium may be slightly higher because platelets release potassium during clotting. The difference may become more important in marked thrombocytosis.

What is pseudohyperkalemia?

Pseudohyperkalemia is a falsely elevated laboratory potassium result that does not accurately represent the patient's circulating potassium. Causes include hemolysis, thrombocytosis, leukocytosis, collection problems, and specimen-handling issues.

Does a potassium blood test require fasting?

Potassium testing alone generally does not require fasting, although fasting may be necessary when other tests are ordered at the same time.

Should I stop medication before a potassium test?

No medication should be stopped unless a healthcare professional specifically advises it. Many drugs affect potassium, but abruptly stopping necessary treatment can be harmful.

Can EDTA contamination cause high potassium?

Yes. Potassium-containing EDTA used in hematology tubes can produce a markedly elevated potassium result if it contaminates a chemistry specimen.

Why can potassium be high when the ECG is normal?

The relationship between serum potassium and ECG changes is not perfectly predictable. A normal-appearing ECG does not exclude clinically important hyperkalemia.

Why might a potassium test need to be repeated?

Repeat testing may be appropriate when the specimen is hemolyzed, contaminated, inconsistent with previous results, affected by collection problems, or clinically unexpected. The decision should follow laboratory and clinical protocols.

What is the best specimen for suspected pseudohyperkalemia?

The optimal specimen depends on the suspected mechanism and laboratory procedure. In suspected thrombocytosis-related pseudohyperkalemia, properly collected heparinized plasma may help because it avoids potassium release associated with serum clotting.

Can high platelets cause high serum potassium?

Yes. Marked thrombocytosis can produce pseudohyperkalemia in serum because platelets release potassium during clotting.

Can high white blood cells affect potassium?

Extreme leukocytosis can cause spurious potassium abnormalities in some situations, particularly when fragile cells are damaged during collection or transport.

Official & Authoritative Sources

NIH / U.S. Government National Institutes of Health — Office of Dietary Supplements Potassium: Health Professional Fact Sheet View official NIH source

NLM / NIH MedlinePlus — Potassium Blood Test U.S. National Library of Medicine View official MedlinePlus source

NLM / NIH MedlinePlus Medical Encyclopedia — Potassium Test Includes specimen information, example reference values, causes of abnormal potassium, and hemolysis considerations. View official MedlinePlus reference

Professional Kidney Guideline UK Kidney Association Clinical Practice Guideline: Management of Hyperkalaemia in Adults View UK Kidney Association guideline

International Kidney Guideline KDIGO — Kidney Disease: Improving Global Outcomes Clinical practice guideline library for kidney disease and CKD management. View KDIGO 2024 CKD guideline

NHS Professional Guidance NHS Specialist Pharmacy Service Acute hypokalaemia in adults: classification and professional guidance. View NHS professional guidance

Sources were selected for medical authority and relevance. 

Diagnostic and treatment decisions should follow current local guidelines, institutional policy, and qualified clinical judgment.

Prepared by Dr. Omar Adwan MedLab Academy

This article is written from a medical laboratory perspective and focuses on specimen quality, analytical methodology, interference recognition, quality control, and responsible interpretation of laboratory results.

Medical Disclaimer This article is provided for medical laboratory education and general informational purposes only. It does not provide an individual diagnosis, treatment plan, medication recommendation, or emergency medical advice. Potassium abnormalities can sometimes be clinically urgent and must be interpreted by qualified healthcare professionals using the patient's symptoms, medical history, medications, ECG findings, kidney function, other laboratory results, and local clinical guidelines. Laboratory reference intervals and critical-value thresholds may vary by institution and analytical method.

Comments